US FDA gives CordenPharma Latina's Italian plant the all clear
CordenPharma Latina has resolved the problems that earned its API and injectable drug facility in Sermoneta, Italy a warning letter from the US FDA last year.
CordenPharma Latina has resolved the problems that earned its API and injectable drug facility in Sermoneta, Italy a warning letter from the US FDA last year.
Cambrex Corporation is adding a new $3.2m, 11,000 square foot analytical laboratory to its High Point, NC-based facility.
Researchers are looking to replace the Rabbit Vaginal Irritation Test for personal lubricants as consumers demand more humane testing practices.
The US FDA has sent a warning letter to Hetero Labs Limited citing GMP violations at its finished dose formulations facility in Telangana, India.
Mahendra Chemicals has been banned from shipping drug ingredients made at its plant in Ahmedabad, India to the US.